MedTrace Logo

A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.

NCT04738019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1022

Last updated 2023-01-12

No results posted yet for this study

Summary

This is an observational study to evaluate the incidence of delayed-onset nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 injected into the facial skin layer.

Conditions

  • Healthy Condition

Interventions

DIAGNOSTIC_TEST

Medical examination or treatment.

Medical examination or treatment when delayed on-set nodule or other side effects occur due to Y-Solution filler injection.

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04738019 on ClinicalTrials.gov